Relief Therapeutics Holding AG (RLFTF)

[PennyWorld]

In a letter to NIAID Director Anthony Fauci and FDA Commissioner Robert Califf, Sen. Ron Johnson (R-Wis.) demanded to know why public health officials ignored three Emergency Use Authorization (EUA) requests from the drug manufacturer, NRx Pharmaceuticals, and refused to review data on ZYESAMI’s efficacy against COVID. The letter, co-authored by Sen. Ted Cruz (R-Texas) and Reps. Andy Biggs (R-Ariz.) and Chip Roy (R-Fla.), cited a physician who treated more than 20 patients who were suffering respiratory failure from COVID-19, and received ZYESAMI as authorized under Right to Try.

Full article...
https://amgreatness.com/2022/03/09/in-letter-to-fda-and-niaid-ron-johnson-demands-to-know-why-promising-late-stage-covid-drug-was-never-approved/